Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Inflammation & Allergy Drug Targets|April 27, 2012
Interleukin-21 in immune and allergic diseasesMassimiliano Sarra, Maria Laura Cupi, Francesco Pallone, et al.
Current Pharmaceutical Design|December 7, 2010
Targeting IL-23 and Th17-cytokines in inflammatory bowel diseasesDaniela De Nitto, Massimiliano Sarra, Maria Laura Cupi, et al.
Plos One|May 13, 2016
Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer CellsIrene Marafini, Ivan Monteleone, Davide Di Fusco, et al.
Clinical Science (London, England : 1979)|March 25, 2015
Interleukin-34 sustains inflammatory pathways in the gutEleonora Franzè, Ivan Monteleone, Maria Laura Cupi, et al.
Plos One|August 8, 2013
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel diseaseEleonora Franzè, Roberta Caruso, Carmine Stolfi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 29, 2011
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasiaMassimiliano Sarra, Roberta Caruso, Maria Laura Cupi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2014
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activitiesMaria Laura Cupi, Massimiliano Sarra, Irene Marafini, et al.
Hepatology (Baltimore, Md.)|April 9, 2013
IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanismMassimiliano Sarra, Maria Laura Cupi, Roberta Bernardini, et al.
Pageof 2